Account
Havas Media bags digital mandate for Wai Wai noodles
NEW DELHI: Havas Media India has won the digital media mandate for Nepal-based Chaudhary Group’s (CG Foods) noodle brand Wai Wai.
The mandate includes digital media and website management. The account will be handled by the agency’s Gurugram office led by Havas Media president – north and west India Uday Mohan
Chaudhary Group global business head – FMCG GP Sah said, “India is a crucial market for us with immense potential and as we chase our ambition to be a global leader, our strategies must be unique to each region we are in. With Havas Media’s market intelligence, digital expertise and its integrated offering, we are confident to take the brand to newer heights and achieve a larger market share.”
Havas Media Group India CEO Mohit Joshi said, “We are excited to kickstart the year with a global FMCG brand from CG Foods. Wai Wai is a challenger brand that operates in an extremely competitive category in India. With Havas Media’s focus on keeping the audience at the centre of the planning exercise is in line with the group’s growing expertise in performance and market-place initiatives, we look forward to positioning the brand in this market and strengthening the brand connect through our meaningful media experience philosophy.”
CG Foods, an enterprise of CG Corp Global, is a company engaged in manufacturing and sales of instant noodles, snacks, sauces and beverages. It has manufacturing footprints in five different countries – India, Nepal, Bangladesh, Kazakhstan (central Asia) and Serbia (Europe). CG Foods India produces Wai Wai in seven different locations across the country and employs more than 3,000 people directly. Its famous product Wai Wai noodles is sold in more than 50 countries.
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
